228 related articles for article (PubMed ID: 11086005)
1. Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice.
Previtali SC; Quattrini A; Fasolini M; Panzeri MC; Villa A; Filbin MT; Li W; Chiu SY; Messing A; Wrabetz L; Feltri ML
J Cell Biol; 2000 Nov; 151(5):1035-46. PubMed ID: 11086005
[TBL] [Abstract][Full Text] [Related]
2. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.
Rünker AE; Kobsar I; Fink T; Loers G; Tilling T; Putthoff P; Wessig C; Martini R; Schachner M
J Cell Biol; 2004 May; 165(4):565-73. PubMed ID: 15148307
[TBL] [Abstract][Full Text] [Related]
3. A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies.
Iida M; Koike H; Ando T; Sugiura M; Yamamoto M; Tanaka F; Sobue G
Neuromuscul Disord; 2012 Feb; 22(2):166-9. PubMed ID: 21940171
[TBL] [Abstract][Full Text] [Related]
4. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation, Thr65Ala, in the MPZ gene in a patient with Charcot-Marie-Tooth type 1B disease with focally folded myelin.
Kochanski A; Drac H; Kabzińska D; Hausmanowa-Petrusewicz I
Neuromuscul Disord; 2004 Mar; 14(3):229-32. PubMed ID: 15036333
[TBL] [Abstract][Full Text] [Related]
6. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
Fledrich R; Schlotter-Weigel B; Schnizer TJ; Wichert SP; Stassart RM; Meyer zu Hörste G; Klink A; Weiss BG; Haag U; Walter MC; Rautenstrauss B; Paulus W; Rossner MJ; Sereda MW
Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569
[TBL] [Abstract][Full Text] [Related]
7. Peripheral nerve dysmyelination due to P0 glycoprotein overexpression is dose-dependent.
Quattrini A; Feltri ML; Previtali S; Fasolini M; Messing A; Wrabetz L
Ann N Y Acad Sci; 1999 Sep; 883():294-301. PubMed ID: 10586254
[TBL] [Abstract][Full Text] [Related]
8. Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to P0 molecular defects.
Kirschner DA; Szumowski K; Gabreëls-Festen AA; Hoogendijk JE; Bolhuis PA
J Neurosci Res; 1996 Nov; 46(4):502-8. PubMed ID: 8950710
[TBL] [Abstract][Full Text] [Related]
9. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
10. MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.
Saporta MA; Shy BR; Patzko A; Bai Y; Pennuto M; Ferri C; Tinelli E; Saveri P; Kirschner D; Crowther M; Southwood C; Wu X; Gow A; Feltri ML; Wrabetz L; Shy ME
Brain; 2012 Jul; 135(Pt 7):2032-47. PubMed ID: 22689911
[TBL] [Abstract][Full Text] [Related]
11. P0S63del impedes the arrival of wild-type P0 glycoprotein to myelin in CMT1B mice.
Fratta P; Saveri P; Zambroni D; Ferri C; Tinelli E; Messing A; D'Antonio M; Feltri ML; Wrabetz L
Hum Mol Genet; 2011 Jun; 20(11):2081-90. PubMed ID: 21363884
[TBL] [Abstract][Full Text] [Related]
12. Role of immune cells in animal models for inherited peripheral neuropathies.
Wang Ip C; Kroner A; Fischer S; Berghoff M; Kobsar I; Mäurer M; Martini R
Neuromolecular Med; 2006; 8(1-2):175-90. PubMed ID: 16775375
[TBL] [Abstract][Full Text] [Related]
13. Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelination.
Hu B; McCollum M; Ravi V; Arpag S; Moiseev D; Castoro R; Mobley B; Burnette B; Siskind C; Day J; Yawn R; Feely S; Li Y; Yan Q; Shy M; Li J
Ann Neurol; 2018 Apr; 83(4):756-770. PubMed ID: 29518270
[TBL] [Abstract][Full Text] [Related]
14. Sustained Expression of Negative Regulators of Myelination Protects Schwann Cells from Dysmyelination in a Charcot-Marie-Tooth 1B Mouse Model.
Florio F; Ferri C; Scapin C; Feltri ML; Wrabetz L; D'Antonio M
J Neurosci; 2018 May; 38(18):4275-4287. PubMed ID: 29610440
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy.
Adlkofer K; Frei R; Neuberg DH; Zielasek J; Toyka KV; Suter U
J Neurosci; 1997 Jun; 17(12):4662-71. PubMed ID: 9169527
[TBL] [Abstract][Full Text] [Related]
16. Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.
Musner N; Sidoli M; Zambroni D; Del Carro U; Ungaro D; D'Antonio M; Feltri ML; Wrabetz L
ASN Neuro; 2016; 8(2):. PubMed ID: 27095827
[TBL] [Abstract][Full Text] [Related]
17. Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice.
Wrabetz L; D'Antonio M; Pennuto M; Dati G; Tinelli E; Fratta P; Previtali S; Imperiale D; Zielasek J; Toyka K; Avila RL; Kirschner DA; Messing A; Feltri ML; Quattrini A
J Neurosci; 2006 Feb; 26(8):2358-68. PubMed ID: 16495463
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of large myelin protein zero leads to Charcot-Marie-Tooth disease-like neuropathy in mice.
Otani Y; Ohno N; Cui J; Yamaguchi Y; Baba H
Commun Biol; 2020 Mar; 3(1):121. PubMed ID: 32170207
[TBL] [Abstract][Full Text] [Related]
19. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A.
Kobsar I; Hasenpusch-Theil K; Wessig C; Müller HW; Martini R
J Neurosci Res; 2005 Sep; 81(6):857-64. PubMed ID: 16041800
[TBL] [Abstract][Full Text] [Related]
20. [Pathology of Charcot-Marie-Tooth Disease].
Oka N
Brain Nerve; 2016 Jan; 68(1):21-9. PubMed ID: 26764296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
